Device manufacturer, as written on reports

Stryker Neurovascular-Utah-Salt Lake City: medical device reports filed with FDA

1,664 reports name it as the manufacturer of the device involved, 2018–2026.

Read first · FDA's statement on these data

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product. openFDA, FDA

FDA adds: "Although MDRs are a valuable source of information, this passive surveillance system has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data. In addition, the incidence or prevalence of an event cannot be determined from this reporting system alone due to potential under-reporting of events and lack of information about frequency of device use." And: "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices."

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

1,664
reports naming it as manufacturer: 0% of all MAUDE reports; 196
reports, 12 months to August 2026: 207 in the 12 months before; 64.6%
classified as malfunction: 62.3% across all reports; 1.6%
classified as death, as reported: 0.9% across all reports

1,664 medical device reports received by FDA give Stryker Neurovascular-Utah-Salt Lake City as the manufacturer of the device involved, 0% of the MAUDE database, from March 2018 to August 2026. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.

196 reports arrived in the 12 months to August 2026, close to the 207 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (64.6%), injury (33.8%) and death (1.6%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands named most often

Brand	Device type	Reports	Latest 12 months	Classified as death
Synchro-14 Straight 200-35cm	Wire, guide, catheter	192	15	0%
Synchro2-14 Standard Straight 200cm	Wire, guide, catheter	161	32	0%
Unknown_Neurovascular_Product	Intracranial neurovascular stent	132	48	12.9%

Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Device types

Product code	Device type	Reports	Share
DQX	Wire, guide, catheter	795	47.8%
MOF	Guide, wire, catheter, neurovasculature	366	22%
NRY	Catheter, thrombus retriever	208	12.5%
DQY	Catheter, percutaneous	179	10.8%
DQO	Catheter, intravascular, diagnostic	23	1.4%
QJP	Catheter, percutaneous, neurovasculature	11	0.7%
OUT	Intracranial aneurysm flow diverter	2	0.1%

Reports by month, five years

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type

Death1.6%27

Injury33.8%562

Malfunction64.6%1,075

Other0%0

Not given0%0

Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.

Questions about Stryker Neurovascular-Utah-Salt Lake City reports

How many FDA device reports name Stryker Neurovascular-Utah-Salt Lake City as manufacturer?

1,664 reports through August 2026, 196 of them in the latest 12 months.

Which of its brands appear most often?

Synchro-14 Straight 200-35cm (192), Synchro2-14 Standard Straight 200cm (161) and Unknown_Neurovascular_Product (132).

Which device types does it report on?

wire, guide, catheter (47.8%), guide, wire, catheter, neurovasculature (22%), catheter, thrombus retriever (12.5%) and catheter, percutaneous (10.8%).

Does a high count say something about the manufacturer?

Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.